Secretory carcinoma of the breast - Revision history

Michael: /* See also */

2019-12-31T15:16:16Z

Michael at 05:57, 11 September 2018

2018-09-11T05:57:44Z

← Older revision		Revision as of 05:57, 11 September 2018
Line 11:		Line 11:
	\| IHC = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve		\| IHC = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve
	\| EM =		\| EM =
	\| Molecular =		\| Molecular = ETV6-[[NTRK3]]
	\| IF =		\| IF =
	\| Gross =		\| Gross =

Michael: /* Molecular pathology */ tweak

2018-09-11T05:44:40Z

Molecular pathology: tweak

← Older revision		Revision as of 05:44, 11 September 2018
Line 64:		Line 64:
	Characteristic translocation:<ref name=pmid22129193/>		Characteristic translocation:<ref name=pmid22129193/>
	*t(12;15).		*t(12;15).
	**ETV6-NTRK3.		**ETV6-[[NTRK3]].

	Note:		Note:

Michael at 11:34, 8 September 2016

2016-09-08T11:34:27Z

← Older revision		Revision as of 11:34, 8 September 2016
Line 14:		Line 14:
	\| IF =		\| IF =
	\| Gross =		\| Gross =
	\| Grossing = [[~~mastectomy~~ grossing]]		\| Grossing = [[breast grossing]]
	\| Staging = [[breast cancer staging]]		\| Staging = [[breast cancer staging]]
	\| Site = [[breast]] - see ''[[invasive breast cancer]]''		\| Site = [[breast]] - see ''[[invasive breast cancer]]''

Michael at 04:13, 1 May 2016

2016-05-01T04:13:12Z

← Older revision		Revision as of 04:13, 1 May 2016
Line 14:		Line 14:
	\| IF =		\| IF =
	\| Gross =		\| Gross =
	\| Grossing =		\| Grossing = [[mastectomy grossing]]
			\| Staging = [[breast cancer staging]]
	\| Site = [[breast]] - see ''[[invasive breast cancer]]''		\| Site = [[breast]] - see ''[[invasive breast cancer]]''
	\| Assdx =		\| Assdx =

Michael at 19:00, 14 February 2014

2014-02-14T19:00:26Z

← Older revision		Revision as of 19:00, 14 February 2014
Line 1:		Line 1:
			{{ Infobox diagnosis
			\| Name = {{PAGENAME}}
			\| Image =
			\| Width =
			\| Caption =
			\| Synonyms =
			\| Micro =
			\| Subtypes =
			\| LMDDx = [[lactational change]]
			\| Stains =
			\| IHC = ER -ve, PR -ve, HER2 -ve, alpha-lactalbumin +ve, S-100 +ve, polyclonal CEA +ve
			\| EM =
			\| Molecular =
			\| IF =
			\| Gross =
			\| Grossing =
			\| Site = [[breast]] - see ''[[invasive breast cancer]]''
			\| Assdx =
			\| Syndromes =
			\| Clinicalhx =
			\| Signs =
			\| Symptoms =
			\| Prevalence = rare
			\| Bloodwork =
			\| Rads =
			\| Endoscopy =
			\| Prognosis = favourable
			\| Other =
			\| ClinDDx =
			\| Tx =
			}}
	'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with lactational changes]]''.		'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with lactational changes]]''.

Michael: /* Molecular pathology */

2014-02-14T10:58:51Z

Molecular pathology

← Older revision		Revision as of 10:58, 14 February 2014
Line 35:		Line 35:

	Note:		Note:
	*This translocation is also seen in [[mammary analogue secretory carcinoma]]<ref name=pmid20410810>{{Cite journal \| last1 = Skálová \| first1 = A. \| last2 = Vanecek \| first2 = T. \| last3 = Sima \| first3 = R. \| last4 = Laco \| first4 = J. \| last5 = Weinreb \| first5 = I. \| last6 = Perez-Ordonez \| first6 = B. \| last7 = Starek \| first7 = I. \| last8 = Geierova \| first8 = M. \| last9 = Simpson \| first9 = RH. \| title = Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. \| journal = Am J Surg Pathol \| volume = 34 \| issue = 5 \| pages = 599-608 \| month = May \| year = 2010 \| doi = 10.1097/PAS.0b013e3181d9efcc \| PMID = 20410810 }}</ref> ~~and~~ [[congenital-infantile fibrosarcoma]].		*This translocation is also seen in [[mammary analogue secretory carcinoma]],<ref name=pmid20410810>{{Cite journal \| last1 = Skálová \| first1 = A. \| last2 = Vanecek \| first2 = T. \| last3 = Sima \| first3 = R. \| last4 = Laco \| first4 = J. \| last5 = Weinreb \| first5 = I. \| last6 = Perez-Ordonez \| first6 = B. \| last7 = Starek \| first7 = I. \| last8 = Geierova \| first8 = M. \| last9 = Simpson \| first9 = RH. \| title = Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. \| journal = Am J Surg Pathol \| volume = 34 \| issue = 5 \| pages = 599-608 \| month = May \| year = 2010 \| doi = 10.1097/PAS.0b013e3181d9efcc \| PMID = 20410810 }}</ref> [[congenital-infantile fibrosarcoma]] and [[mesoblastic nephroma]].

	==See also==		==See also==

Michael: /* See also */

2014-02-14T10:58:15Z

Michael at 10:57, 14 February 2014

2014-02-14T10:57:01Z

← Older revision		Revision as of 10:57, 14 February 2014
Line 1:		Line 1:
	'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with ~~secretory~~ changes]]''.		'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with lactational changes]]''.

	It is also known as '''secretory breast carcinoma''' (abbreviated '''SBC''') and '''breast secretory carcinoma'''.		It is also known as '''secretory breast carcinoma''' (abbreviated '''SBC''') and '''breast secretory carcinoma'''.

Michael at 10:56, 14 February 2014

2014-02-14T10:56:22Z

← Older revision		Revision as of 10:56, 14 February 2014
Line 1:		Line 1:
	'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with secretory changes]]''.		'''Secretory carcinoma of the breast''' is an uncommon form of [[invasive breast cancer]] that has an appearance similar to ''[[breast with secretory changes]]''.

	It is also known as '''secretory breast carcinoma''', abbreviated '''SBC'''.		It is also known as '''secretory breast carcinoma''' (abbreviated '''SBC''') and '''breast secretory carcinoma'''.
	==General==		==General==
	*Favourable prognosis.<ref name=pmid22129193>{{Cite journal \| last1 = Vasudev \| first1 = P. \| last2 = Onuma \| first2 = K. \| title = Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. \| journal = Arch Pathol Lab Med \| volume = 135 \| issue = 12 \| pages = 1606-10 \| month = Dec \| year = 2011 \| doi = 10.5858/arpa.2010-0351-RS \| PMID = 22129193 }}</ref>		*Favourable prognosis.<ref name=pmid22129193>{{Cite journal \| last1 = Vasudev \| first1 = P. \| last2 = Onuma \| first2 = K. \| title = Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. \| journal = Arch Pathol Lab Med \| volume = 135 \| issue = 12 \| pages = 1606-10 \| month = Dec \| year = 2011 \| doi = 10.5858/arpa.2010-0351-RS \| PMID = 22129193 }}</ref>

← Older revision		Revision as of 15:16, 31 December 2019
Line 71:		Line 71:
	==See also==		==See also==
	*[[Invasive breast cancer]].		*[[Invasive breast cancer]].
	*[[~~Mammary~~ analogue secretory carcinoma]].		*[[Secretory carcinoma of the salivary gland]] (previously known as ''mammary analogue secretory carcinoma'').
	*[[Congenital-infantile fibrosarcoma]].		*[[Congenital-infantile fibrosarcoma]].

← Older revision		Revision as of 10:58, 14 February 2014
Line 39:		Line 39:
	==See also==		==See also==
	*[[Invasive breast cancer]].		*[[Invasive breast cancer]].
			*[[Mammary analogue secretory carcinoma]].
			*[[Congenital-infantile fibrosarcoma]].

	==References==		==References==